dotter: Cardiovascular Diagnostic and Treatment Software
dotter helps medical practices and hospitals analyze cardiovascular procedures and select stents. It is designed for cardiology teams requiring high-resolution imaging and real time analysis.
At a glance
- Category
- Browse Healthcare tools
- Best for
- Medical Practices, Hospitals, Cardiology Departments
- Pricing
- Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
- Key use cases
- Real Time Procedure Analysis, Lesion Assessment, Stent Apposition Confirmation
- Official website
- Visit dotter official website
dotter is a healthcare technology provider specializing in the diagnosis and treatment of ischemic heart disease. The company offers a combination of hardware and software, including the Aurios S100 OCT imaging system and accompanying AI-based analysis tools.
The software is designed for use during PCI procedures, providing real time morphological analysis and 3D stereoscopic images of the artery. It supports clinicians in assessing lesion locations, determining stenosis rates, and confirming the apposition status of inserted stents.
Beyond software, dotter provides medical devices such as bioresorbable stents, imaging catheters, and balloon catheters. This integrated approach is designed to support workflows from lesion analysis to patient recovery.
Buyers should confirm the regulatory approval status and availability of these tools in their specific region, as some systems have received Korean regulatory approval.
Key Features
AI-Based Real Time Analysis
Software that uses artificial neural networks to analyze cardiovascular procedures in real time.
High-Resolution OCT Imaging
Optical coherence tomography that provides imaging for lesion assessment and stent selection.
Morphological Analysis
Provides internal diameter contouring and profile display functions during procedures.
3D Stereoscopic Visualization
Converts recorded cardiovascular images into 3D images to observe the artery and stent placement.
Stenting Assistant
Provides minimal lumen area and stenosis rate information to assist in stent selection.
Use Cases
Real Time Procedure Analysis
Using AI software to monitor and analyze cardiovascular procedures as they happen.
Lesion Assessment
Performing high-resolution OCT imaging to analyze stenosis and determine the appropriate stent.
Stent Apposition Confirmation
Using 3D imaging to verify the status of drug-eluting or bioresorbable stents after insertion.
Best For
- Medical Practices
- Hospitals
- Cardiology Departments
Pricing
Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
FAQ
What does dotter's AI software do?
- It provides real time analysis of cardiovascular procedures and uses artificial neural network learning to help analyze disease risk and establish treatment plans.
Who is dotter's software designed for?
- It is designed for medical professionals in hospitals and medical practices treating patients with ischemic heart disease and other cardiovascular conditions.
Does dotter provide hardware as well as software?
- Yes, dotter provides the Aurios S100 OCT imaging system, Benetis catheters, and various types of stents alongside its analysis software.
Source category: Healthcare
Source subcategory: Medical Diagnostics
More tools in Healthcare
Other published listings in the Healthcare category.
More tools tagged “Medical Diagnostics”
Related listings that share the same software type tag.
Categories
Software Type
How AI is used
dotter is a healthcare technology provider for hospitals and medical practices, offering AI-based software for real time cardiovascular procedure analysis and OCT imaging. It supports workflows for lesion assessment and stent placement. Buyers should verify regional regulatory approval before adoption.
Pros & Cons
Pros
- Combines AI software with physical diagnostic hardware
- High-resolution imaging capability for intravascular technology
- Supports both drug-eluting and bioresorbable stent workflows
Cons
- Pricing and subscription tiers are not detailed in available evidence
- Regulatory availability may be limited by region
- Administrative controls and user permission management are not described
